Baudax Bioinc Stock Today

BXRX Stock  USD 0.02  0.0004  2.34%   

Performance

2 of 100

 
Low
 
High
Weak

Odds Of Distress

Over 87

 
100  
 
Zero
Very High
Baudax BioInc is trading at 0.0167 as of the 19th of March 2024; that is -2.34 percent decrease since the beginning of the trading day. The stock's open price was 0.0171. Baudax BioInc has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Baudax BioInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2023 and ending today, the 19th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of November 2019
Category
Healthcare
Classification
Health Care
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 43.59 M outstanding shares of which 493.56 K shares are currently shorted by private and institutional investors with about 0.19 trading days to cover. More on Baudax BioInc

Moving together with Baudax Stock

  0.61VALN Valneva SE ADR Earnings Call TomorrowPairCorr

Moving against Baudax Stock

  0.66APGE Apogee TherapeuticsPairCorr
  0.64A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.63JANX Janux Therapeutics Financial Report 14th of May 2024 PairCorr
  0.58REVBW Revelation BiosciencesPairCorr
  0.52SLS Sellas Life Sciences Report 21st of March 2024 PairCorr
  0.48ALVO Alvotech Earnings Call This WeekPairCorr
  0.45REGN Regeneron Pharmaceuticals Financial Report 2nd of May 2024 PairCorr

Baudax Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Baudax BioInc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Baudax BioInc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO PresidentGeraldine Henwood
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Baudax BioInc report their recommendations after researching Baudax BioInc's financial statements, talking to executives and customers, or listening in on Baudax BioInc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Baudax BioInc. The Baudax consensus assessment is calculated by taking the average forecast from all of the analysts covering Baudax BioInc.
Financial Strength
Based on the measurements of operating efficiency obtained from Baudax BioInc's historical financial statements, Baudax BioInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. Financial strength of Baudax BioInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.120.11
Significantly Up
Slightly volatile
Total Current Liabilities17.4 M19.3 M
Moderately Down
Slightly volatile
Non Current Liabilities Total11 M11.5 M
Notably Down
Slightly volatile
Total Assets8.6 MM
Notably Down
Pretty Stable
Total Current Assets6.9 M7.3 M
Notably Down
Slightly volatile
Baudax BioInc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Baudax BioInc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Baudax BioInc's financial leverage. It provides some insight into what part of Baudax BioInc's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Baudax BioInc's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Baudax BioInc deploys its capital and how much of that capital is borrowed.
Liquidity
Baudax BioInc cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax BioInc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Baudax BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Baudax BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baudax BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baudax to invest in growth at high rates of return. When we think about Baudax BioInc's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

(2.03 Million)
Baudax BioInc (BXRX) is traded on NASDAQ Exchange in USA and employs 9 people. Baudax BioInc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 950.33 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Baudax BioInc's market, we take the total number of its shares issued and multiply it by Baudax BioInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Baudax BioInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 43.59 M outstanding shares of which 493.56 K shares are currently shorted by private and institutional investors with about 0.19 trading days to cover. Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Baudax BioInc Probability Of Bankruptcy
Ownership Allocation
Baudax BioInc holds a total of 43.59 Million outstanding shares. Almost 97.0 percent of Baudax BioInc outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 2.68 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Baudax Ownership Details

Baudax Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Baudax BioInc jumping above the current price in 90 days from now is about 91.28%. The Baudax BioInc probability density function shows the probability of Baudax BioInc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Baudax BioInc has a beta of -2.0841 suggesting as returns on its benchmark rise, returns on holding Baudax BioInc are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Baudax BioInc is expected to outperform its benchmark. Moreover, the company has an alpha of 1.1865, implying that it can generate a 1.19 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.0167HorizonTargetOdds Above 0.0167
8.68%90 days
 0.02 
91.28%
Based on a normal probability distribution, the odds of Baudax BioInc to move above the current price in 90 days from now is about 91.28 (This Baudax BioInc probability density function shows the probability of Baudax Stock to fall within a particular range of prices over 90 days) .

Baudax Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Baudax BioInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Baudax BioInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Baudax BioInc's value.
InstituionRecorded OnShares
Virtu Financial Llc2023-12-31
0.0
Sittner & Nelson, Llc2023-09-30
0.0
Blackrock Inc2023-12-31
0.0
Advisor Group Holdings, Inc.2023-12-31
0.0
Xtx Topco Ltd2023-12-31
0.0
Creative Planning Inc2023-09-30
0.0
State Street Corporation2023-12-31
0.0
Susquehanna International Group, Llp2023-12-31
0.0
Wells Fargo & Co2023-12-31
0.0
Jane Street Group, Llc2023-09-30
0.0
Tower Research Capital Llc2023-12-31
0.0
View Baudax BioInc Diagnostics

Baudax BioInc Historical Income Statement

Baudax BioInc Income Statement is one of the three primary financial statements used for reporting Baudax's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Baudax BioInc revenue and expense. Baudax BioInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Baudax BioInc's Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 25.4 M in 2024, whereas Operating Income is likely to drop (36.8 M) in 2024. View More Fundamentals

Baudax Stock Against Markets

Picking the right benchmark for Baudax BioInc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Baudax BioInc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Baudax BioInc is critical whether you are bullish or bearish towards Baudax BioInc at a given time. Please also check how Baudax BioInc's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Baudax BioInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Baudax BioInc Corporate Management

Elected by the shareholders, the Baudax BioInc's board of directors comprises two types of representatives: Baudax BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baudax. The board's role is to monitor Baudax BioInc's management team and ensure that shareholders' interests are well served. Baudax BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baudax BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Natalie McAndrewConsultant OfficerProfile
Jillian DilmoreCorp ControllerProfile
Diane MyersVP QualityProfile
Mike ChoiVice AnalysisProfile

How to buy Baudax Stock?

Before investing in Baudax BioInc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Baudax BioInc. To buy Baudax BioInc stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Baudax BioInc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Baudax BioInc stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Baudax BioInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Baudax BioInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Baudax BioInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.

Already Invested in Baudax BioInc?

The danger of trading Baudax BioInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Baudax BioInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Baudax BioInc. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Baudax BioInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(94.13)
Revenue Per Share
0.318
Quarterly Revenue Growth
(0.23)
Return On Assets
(1.15)
Return On Equity
(47.04)
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.